© 2020 – 2023 AEA3 WEB | AEAƎ United Kingdom News
AEA3 WEB | AEAƎ United Kingdom News
News

MS patients in England to benefit from major roll out of take-at-home pill

Cladribine tablet for those with active multiple sclerosis will reduce hospital visits and free up appointments

Thousands of patients with multiple sclerosis (MS) in England are to become the first in Europe to benefit from a major roll out of an immunotherapy pill.

Current treatments involve regular trips to hospital, drug infusions, frequent injections and extensive monitoring, which add to the burden on patients and healthcare systems.

Continue reading…

Related posts

Hundreds moved from Manston migrant centre amid overcrowding

AEA3

Mikhail Gorbachev, Soviet leader who ended cold war, dies aged 91

AEA3

Deal with EU will make food cheaper and add £9bn to UK economy, says No 10

AEA3

Pin It on Pinterest

Share This